Skip to main content
Industry News
Mallinckrodt settles kickback, Medicaid fraud allegations for $15.4M

Drugmaker Mallinckrodt agreed to a $15.4 million settlement to resolve accusations that Questcor Pharmaceuticals, now owned by Mallinckrodt, provided doctors with meals and entertainment to encourage prescribing of its Acthar gel for multiple sclerosis and other diseases. Authorities said the alleged scheme resulted in the submission of fraudulent claims to Medicare.

Full Story: